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Introduction 
This chapter examines technologies of 'treatment scaleup,' the extension of antiretroviral 
treatment (ART) to most or all of HIV positive people who need it, in the Western Cape, 
South Africa. The chapter describes three technologies related to ART scaleup: those of 
administration; partnership,  rather different to the 'partnership' Campbell (this volume) 
describes and thirdly what we refer to as treatment citizenship. These non-medical 
treatment technologies operate alongside conventional medical treatment technologies to 
make up a successful, even exemplary ART scaleup. The chapter also argues that the 
success of these technologies derives from their involvement in a larger phenomenon: a 
new construction of  'HIV citizenship' within the Western Cape.                                     
 
The Western Cape’s ART programme, begun in April 2004, was the first treatment scale-
up to high levels of provision within a high-prevalence low-resourced context. At the 
time, many politicians, policymakers and clinicians thought that delivering ART 
programmes in such settings was dangerous or impossible. Today, the programme's 
success and influence, particularly for other developing-world scaleup programmes, is 
widely acknowledged (World Health Organisation, 2007). The Western Cape’s earlier 
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demonstration projects, starting in 2001 in the township of Khayelitsha, near Cape Town 
(Coetzee et al., 2004), were important models for the World Health Organisation 
(WHO)’s ‘3 by 5’ programme, aiming to provide ART to 3 million HIV positive people 
by 2005 - a goal met two years late (see 
http://www.who.int/mediacentre/factsheets/2003/fs274/en/ and World Health 
Organisation, 2006). The first author of this chapter headed Western Cape AIDS 
programmes from 1996 to 2005, and directed the scaleup (Abdullah, 2004, 2006; 
Abdullah et al., 2006; Boulle et al., 2008). He now works with the Global Fund to Fight 
AIDS, Tuberculosis and Malaria, as Africa Unit Director, again with scaleup a priority. 
The second author conducted interviews about HIV support with HIV positive people in 
the Western Cape between 2001-4, when many interviewees were beginning or 
contemplating ART (Squire, 2007).  This chapter draws predominantly on the first and to 
a lesser extent on the second area of work. 
 
How did particular technologies deliver the Western Cape scaleup? This chapter takes 
technologies to be "hybrid assemblages" (Rose, 2007: 17) of knowledges, practices and 
material resources that have particular effects. In this case, they are directed at enabling 
people with HIV-related illness to be healthy, happy and socially active. The 'hybrid' 
diversity of the administrative, partnership and treatment citizenship technologies 
examined here renders them heterogeneous; they intersect with and sometimes contradict 
each other.  And power does not lie only with the technologies’ makers and controllers. 
Their natures, applications and ownership are contested by everyone involved with them.  
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Administrative technologies are rarely examined in accounts of HIV treatment. Lacking 
clear or appealing politics, they usually appear simply as bureaucracy. However, they can 
have important political effects, as well as treatment effectiveness, depending on how 
their ownership is structured. In this chapter, they counter the instances Campbell 
describes of determining and surveillant, top-down bureaucratisation. Partnership 
technologies, often present solely in the discourse of the more powerful partners, can also 
be to some extent delivered in practice - as Campbell's chapter demonstrates, and this 
chapter reiterates. What we are calling 'treatment citizenship' technology is harder to 
describe, lying in the fields of education, social dialogue and community action. Elements 
of it are however frequently identified as contributing to the success of HIV programmes. 
In the Western Cape scaleup, treatment citizenship's effectiveness is very clear.   
 
The chapter suggests that that these technologies worked within a larger frame of 
developing discourses and practices of 'HIV citizenship'. This concept has some 
important precedents. Rabinow (1996) describes a 'biosocial' realm of collectively 
articulated experience and organisation, through which human subjects engage critically 
and sometimes effectively with discourses of post-nineteenth century biopower (Foucault, 
1980). Rose (2007: 134) frames this "collectivising moment" as one aspect of 'biological 
citizenship.’ Such citizenship, constituted by individualising biopower, allows some 
space for subjects to wrest some power for themselves, individually and collectively, on 
the basis of their ‘vital interests’. Rose cites HIV activism as an example of biological 
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citizenship; others include genetic citizenship, bioinformational citizenship, and 
biopolitical citizenship generally, a category into which HIV activism may fall.Robins 
(2008) frames South African HIV activism as 'health citizenship', a description that 
attends both to the country's radical constitutional guarantee of healthcare for all, and to 
the necessarily integrated nature of healthcare activism in developing-world contexts, 
where access to all medical care, not just ART, is restricted, and where health is 
undermined by hunger and poor infrastructure as well as disease. Robins focuses on HIV 
activists, for whom making connections between HIV and other issues is central to 
political effectiveness. Our concern with the Western Cape ART programme, however, 
takes in the whole of the province's HIV positive population, even those with little 
connections to non-medical services; addresses the specificities of HIV treatment needs 
and makes attention to HIV citizenship more appropriate.   
 
Citizenship for an HIV-infected or affected person has to be constructed in relation to the 
particularities of HIV: its fatal or, since the mid-1990s, potentially chronic character; its 
stigmatisation and associations with socially 'transgressive' sexualities and drug use; its 
national significance in high-prevalence countries, particularly  in sub-saharan Africa and 
its global politics which imbricates all HIV positive people in transnational as well as 
local debates. These specific characteristics, as well as the more general health and 
biological components of HIV citizenship, shape HIV technologies like those driving the 
Western Cape's scaleup. 
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Despite the success of the Western Cape programme, problems remain.  There are 
difficulties of sustainability, accountability and democracy in the programme's systems, as 
well as in its local, national and international governance. Treatment does not work for 
everyone; has sideeffects and may need to change periodically. It also produces fresh 
challenges in people's lives as HIV becomes a long-term but still-stigmatised and 
potentially fatal illness, with new implications for employment, family roles and sexual 
relationships. In epidemics where prevalence and incidence (annual new cases) remain 
high, as in South Africa, the economic future of ART is hard to guarantee without 
factoring in effective prevention; treatment's relation to prevention is also much debated.  
Universal ART can have resource-diverting implications for other public services, 
particularly health, and for the voluntary sector. The successful scaleup technologies and 
discourses and practices of HIV citizenship described in this chapter do not circumvent 
the problems of 'development' Campbell adumbrates when discussing 'partnership' and 
'capacity building'. Western Cape scaleup experiences also indicate that novel 
‘psychosocial’ issues continually arise. Nevertheless, this chapter suggests that the 
Western Cape scaleup demonstrates the possibility of treatment technologies operating 
effectively in high-prevalence, low-resource contexts, as part of broader formations of 
HIV citizenship, pragmatically aligning effectiveness with medical and political hope. 
 
The next sections of the chapter describe the context and nature of the scaleup, before 
examining the three technologies, and their current and future limitations 
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Anti-retroviral treatment: A ‘universal’ technology? 
One of the UN Millenium Development Goals is to "combat HIV/AIDS, malaria and 
other diseases'' and halt HIV’s spread by 2015 (http://www.un.org/millenniumgoals/). 
The UN, G8 and African Union pledge treatment and care for HIV to 80% of those who 
need it, and 25% reductions in HIV prevalence, by 2010. Three million people are now 
thought to be taking ART (World Health Organisation, 2008), the most effective medical 
treatment for people with serious HIV illness – up from 400 000 in 2003 (World Health 
Organisation, 2006). This medical treatment technology has powerful consequences, 
markedly decreasing HIV mortality and prolonging life. In the developed world, many 
HIV positive people are now living in their second decade of treatment.  When treatment 
is generally available, people access it when they are healthier and more likely to do well 
(Boulle et al., 2008). When HIV positive people on ART have unsafe sex, there is less 
likelihood of them transmitting HIV. When HIV positive women on ART have children, 
those children are less likely to have HIV (Jackson et al., 2007). Expanded treatment also 
reduces the pandemic’s psychosocial, economic and political effects - especially 
significant for high-prevalence epidemics in subsaharan Africa. By turning HIV from a 
fatal condition into a manageable, if difficult, chronic illness, ART reduces stigma (Wolfe 
et al., 2008) and enables disclosure (Skogmar et al., 2006) and this in turn encourages 
testing, and others’ early, successful treatment (Chesney and Smith, 1999). ART means 
less strain on health services, more people working, more parents looking after children, 
fewer orphans. It ameliorates the lives of some of the most disadvantaged people in the 
world. Its absence, and communities’ resulting decimation by HIV, can lead to powerful 
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social and political disaffection. 
 
'Universal' ART provision is hard to attain. It is economically, institutionally and socially 
difficult to implement, and the pandemic, the virus, and treatment itself are uncertain and 
changing . ART is prohibitively expensive, particularly those second-line and later 
variants not available as generics, for high-prevalence low- and middle-income countries. 
These countries are therefore positioned as perpetual aid recipients, sourcing a significant 
share of ART’s cost from international donors such as PEPFAR and the Global Fund. As 
epidemics ‘mature’ and more people get ill, as new infection rates remain high, as HIV 
diverts or is perceived to divert resources from additional important health and other 
basic needs and as international NGOs backpedal on or struggle to meet – depending on 
your perspective – their universal treatment commitments, ART’s sustainability is often 
questioned. ART is also said to be potentially enabling transmission by presenting HIV as 
a manageable chronic illness, untransmissible when treated (Davis, this volume), turning 
it into a medicalised, technologically-determined condition, and obviating HIV 
prevention, without which the possibility of universal treatment recedes further.  
 
An early objection to universalising treatment in developing-world epidemics was that 
complicated medications could not work for resource-deprived people, adherence would 
be poor and resistance would grow. However, adherence is higher in developing- than 
developed-world epidemics, and adherence-related resistance is low (Boulle et al., 2008). 
Another objection is that  ‘gold-standard’ ART treatment programmes, medically on par 
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with the developed world and providing ‘wraparound’ social services, are divisive 
resource misuse. As Lee (2006), head of the ‘3 by 5’ programme, notes against this west-
centred criticism, such programmes are not viewed as over-provision in their own 
context. Similarly, the organisation Partners for Health, responsible for innovative HIV 
treatment in Haiti and Malawi, opposes dual-track care, suggesting treatment "should be 
both medical and moral…based on solidarity, rather than charity alone", involving 
"everything that the providers would do for their families - or themselves" 
(http://www.pih.org/who/vision.html).  
 
Do the difficulties of universal treatment mean that there will continue to be 'us' and 
'them' HIV epidemics, distinguished by ART access and its lack?  This chapter argues 
that we are living neither with two treatment-differentiated epidemics, nor in the ‘post-
crisis’ situation described in some developed-world communities with treatment access 
(Rofes, 1998) but rather in a stage characterised by universalised HIV knowledge, 
including treatment knowledge, but uneven provision and expectations. This is still a 
‘treatment possibility’ rather than a ‘treatment' era. This stage nevertheless raises some 
common debates across the diversity of national epidemics, about how ART technologies, 
as well as HIV care, education and support technologies, are working, and how they could 
operate better.   
 
Scaling up ART in a high HIV-prevalence province 
South African addresses to treatment technologies are instructive to consider since the 
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country has high prevalence – 16% among adults (UNAIDS, 2008) - and more people on 
treatment than any other nation. Despite great economic diversity, South Africa is a 
middle-income nation, with relatively well-developed health services and infrastructure in 
urban and periurban areas. Today, between 28% and 42% of the approximately 900 000 
people estimated to need treatment, are receiving it (World Health Organisation, 2008; 
Republic of South Africa, 2008). In 2004, when the Western Cape province's ART 
scaleup began, there were no government plans to provide ART. In a reconstructing 
country faced with five million people dying from HIV-related illnesses within a decade, 
and with relatively good internal and external resources, treatment seemed to many both 
an ethical necessity and an economic and practical possibility.  
 
In 2004, the Western Cape decided to make ART, previously restricted to a small number 
of sites, available to all the people in the province who needed it. Currently around two-
thirds of those thought to need ART in the province, are taking it. On conservative 
calculations, 72% of the first adult and 85% of the first child patients, many of whom 
started treatment when very sick and who came from a highly mobile periurban 
population, are still in the programme (Boulle et al., 2008). Life expectancy when they 
started was at most one year. 
 
At the beginning of scaleup, Western Cape HIV prevalence in the Western Cape was 
estimated at 200 000 – 300 000 out of a 4.2m population 
(http://www.capegateway.gov.za/eng/your_gov/305). 10-20% needed ART according to 
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WHO guidelines on treatment. HIV affects fewer people, proportionally (13%, from 
antenatal screening) and in absolute numbers, than in other South African provinces, 
because of the population’s higher socioeconomic status and because the most HIV-
affected, black-African community in South Africa constitutes a relatively small fraction 
of the Western Cape population. However, antenatal prevalence in some districts reaches 
33%. The province's resources, better overall than those of others, are low in rural areas, 
posing considerable scaleup challenges in some heavily-affected districts. The health 
service suffers chronic understaffing, poor management and organisation, and lack of 
computerisation. There are eight million visits per year to clinics and four million visits 
per year to community health centres (Abdullah et al., 2006); by 2010, 25% will be for 
HIV (Abdullah, 2004).  
 
Demonstration ART programmes at innovator sites had early success in the province in 
2001 (Coetzee et al., 2004), building on the succcess of  Prevention of Mother-To-Child 
Transmission, or PMTCT, programmes which the provincial health department had 
begun in 1998. After court action by activists against the government, who said it would 
be unworkable and too expensive, these successful, cheap and popular PMTCT 
programmes rolled out nationwide, albeit slowly, from 2001 (Moodley et al., 2003); but 
PMTCT was accessible throughout the Western Cape by 2003. Currently, Western Cape 
transmission rates for HIV positive women are 6.1% (Draper et al., 2007). The province’s 
early-adopted and rolled-out PMTCT programmes formed an important treatment literacy 
foundation for patients and staff, particularly in the early stages of the ART scaleup. 
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By April 2004, when the national ART plan was implemented, the Western Cape already 
had 16 ART sites, treating 2327 people with Stage IV HIV illness or CD4 counts below 
200/mm3 – a fourfold increase over the previous six months (Coetzee et al, 2004; 
Western Cape Department of Health, 2006).  The province then rolled out ART to all 
major towns at 43 sites, two-thirds in primary care settings. 7-10,000 people died in 2005 
without accessing ART, but by March 2006, numbers had reached 16 234 adult and child 
patients on treatment - 65% coverage for both groups (Boulle et al., 2008). Figures for 
2008 doubled, at 37 500 (Uys, 2008). 
 
Criteria for success in the Western Cape ART programme are high levels of patients 
retained in care, and high levels of viral suppression amongst those patients. At the end of 
scaleup patients' first year on treatment, 75% had a CD4 count above 200 cells/mm3. This 
figure increased to 86% at two years and 95% at four years on ART. Viral load tests 
showed 88% of adult patients achieving virological suppression after a year on ART and 
85% showing suppression after 4 years. In this treatment-naïve population, virological 
suppression could be expected; but the rate is still very good in comparison with other 
rich and developing countries. Deaths in the first six months of treatment are now half 
what they were initially, as less-ill people seek treatment. 17% of patients are on second 
line therapy after four years (Boulle et al., 2008). 
 
ART’s expansion and success in the Western Cape demonstrate ART scale-up's 
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feasibility in resource-constrained settings. The scale-up started in a situation of low 
national HIV resourcing and education, relatively low levels of local health and social 
resources; low government commitment, patchy international commitment, pre-Global 
Fund, and the numerically largest national epidemic, with still-increasing incidence. In 
such circumstances, scaleup success merits attention. How did it happen? 
 
In the Western Cape programme, pre-ART care for people living with HIV is provided 
mainly at local clinics and comes predominantly from nurses, who conduct voluntary 
counselling and testing, provide care for minor ailments, give ongoing counselling, and 
are responsible for regular checkups including six-monthly CD4 counts. Community 
health centres or district hospital outpatient departments initiate and maintain ART. HIV 
services, particularly ART programmes, always work with local NGOs and community-
based organisations (CBOs). How this occurs, depends on agreements between specific 
health facilities and the organisations. These agreements involve HIV prevention and 
education NGOs and CBOs, as well as those focusing on ART literacy and support, and 
NGOs and CBOs with other remits such as counselling, advocacy, income generation, 
homecare and childcare. ART clinics, support services and PMTCT programmes are 
located close together, usually in the same building. ART delivery is always accompanied 
by education and counselling or peer support. It includes encouragement to disclose to at 
least one person in the patient’s home environment. Again, its specific nature is 
determined by clinicians and NGOs or CBOS, but the programme emphasises 
‘psychosocial’ factors such as understanding and accepting HIV status; ‘positive’ ways of 
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living with HIV in sexual relationships, in having children, and in nutrition, exercise and 
drug and alcohol consumption; and family and friendship network disclosure and support. 
There are strict protocols for patient recruitment, medication, and monitoring ART and 
other health progress, sometimes exceeding WHO guidelines. There is a firmly-
guaranteed supply of ART drugs, not easy where ART provision depends significantly on 
international donors. There is good additional care - secondary referrals for TB, immune 
reconstitution disease, and major side-effects - which enables good adherence. There are 
special arrangements for children, and for patients who are pregnant or who have 
psychiatric issues. Partnerships with national and international NGOs are actively pursued 
(Abdullah, 2004). 
 
Political technologies of scaleup 
We might expect, from South Africa’s political contests around HIV and the country’s 
politicised recent history, that ART scaleup would involve political technologies: explicit 
contests over power relations. However, as the above description indicates, there were no 
explicit political alignments within the programme. Political commitment from national 
leaders, is often declared critical in tackling HIV epidemics, as in Uganda and Botswana  
(Epstein, 2006).  In 2004, South Africa’s governing ANC exhibited considerable 
disengagement from HIV. The Western Cape’s political unpopularity at national level, 
because of its privilege and conservatism and the ANC's weaker position there, 
paradoxically enabled provincial support of ART scaleup and even of treatment HIV 
activism such as that of the Treatment Action Campaign (TAC). Later, as national health 
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policy shifted towards ART scaleup, the Western Cape gained the position, highly 
unusual for this province, of national exemplar. 
 
It might seem likely that the Western Cape scaleup’s success drew on grass-roots 
traditions of political activism derived from the anti-apartheid struggle. This link is, 
though, hard to substantiate. Some NGO, CBO and health service workers and volunteers 
involved in the scaleup had participated in 1980s United Democratic Front campaigns, 
and in lesbian and gay activism; most had no such histories. Moreover, many of the 
health and social service professionals, civil servants, politicians, advocates and activists 
involved were too young for their efforts to be understood as a direct legacy of anti-
apartheid struggle. The indirect legacy of this struggle for South Africa’s HIV campaigns 
is indeed significant (Robins, 2008). It is possible, too, that the Truth and Reconciliation 
Commission's high-profile disclosures enabled HIV activism in the Western Cape's 
relatively politically open context. However, the context of the Western Cape scaleup, 
these legacies were only part of a multi-level technological network. 
 
Administrative technologies of scaleup 
The technologies of the scaleup can be understood as first of all administrative rather than 
political govermentality. The scaleup’s managerial sophistication has often been noted as 
distinguishing it from other provinces’ programmes (Abdullah, 2004; Beresford, 2004). 
Administration acted as a kind of politics in itself, counteracting the simplifications and 
paralyses produced by ‘politics-first’ approaches to the pandemic demonstrated well in 
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Campbell (this volume). Like conventional political technologies, this administrative 
technology involved decision-making and promoting change. Administration – a term 
derived from a word for ‘service’ – became, in the scaleup, a patient-centred, patient-
serving political strategy.  
 
The scale-up was planned by health department officials in consultation with clinicians 
and international, national and local NGOs. In addition to following WHO protocols and 
providing referrals for difficult issues, the health department asked clinics to develop 
broad psychosocial guidelines across all aspects of the programme. For instance, some 
selection guidelines addressed clinic attendance, successful TB treatment, treatment 
literacy, and substance abuse issues. Support guidelines focused on adherence issues, but 
also less immediately relevant concerns such as relationships. The structure and content 
of psychosocial support does not seem to have affected ART outcomes, but support 
perceived as well-administered was judged to perform best (Infectious Disease 
Epidemiology Unit/Department of Health, 2006).  
 
The province put special effort into working with pharmacological services on drug 
sourcing and distribution. Previous province health initiatives had not addressed these 
services, but they were key for a programme depending on a rapid increase, province-
wide, in drug availability; on imported drugs involving complex ordering and processing; 
on low-supply, high-demand drugs liable to 'leak' from the system and on a treatment 
protocol opposed by government and therefore liable to experience national-level 
74 
 
 
 
 
administrative delays. The province also instituted programme-wide ‘basics first’ 
monitoring of patient retention, progress, amount and rate of antiretroviral drugs used, 
and – via treatment waiting time guidelines - care quality. This thorough and painstaking 
monitoring required already hard-worked professionals to keep additional detailed 
handwritten records. More complex data were collected from ‘sentinel’ sites with 
electronic access (Boulle et al., 2008; Western Cape, 2007). The data were powerful 
ripostes to arguments about the impossibility of making ART treatment work in 
generalised high-prevalence low-resource epidemics. Some procedures and data turned 
out to be unnecessarily cautious and detailed. Adherence and loss to followup, addressed 
and defined more strictly than in developed-world programmes, proved less than 
expected, and viral rebound rates have not been high (Boulle et al., 2008). However, such 
'overadministration' was a highly effective strategy, rendering the programme politically 
impregnable and building commitment to and confidence in it among patients and staff.  
 
The politics of biocapital (Sunder, 2006), an economic form dedicated to extracting 
surplus financial and epistemic value from the ‘vital’ properties of living organisms 
(Rose, 2007), tends towards the minimum, quickest-achievable standards of 
administrative care, that will substantiate the value rather than the shortcomings of 
biological science. The administrative technology of this biocapital rollout was by 
contrast highly cautious and regulatory. It shared, however, one common characteristic of 
biocapital development: rapidity.  
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Speed was important to reach people in this escalating epidemic; to try to reduce 
transmission through education and lower infectivity by treatment; to get treatment to 
people when they were at manageable numbers and before it was too late for them and to 
establish treatment structures for the larger numbers who would need them later. To 
achieve this, the programme’s management structures had to be rapidly effective. From 
the beginning, they had to provide drugs consistently, and to sustain an infrastructure that 
would let drugs be prescribed and taken effectively, encouraging adherence and 
minimising the development of resistance. Speed was promoted by putting policy and 
planning targets into the annual budget: the budget itself became a scaleup tool. Often this 
involved informed approximations (Abdullah, 2004). The programme had to estimate 
numbers of patients by site and then allocate appropriate budgets for drugs and labs, 
counsellors, nutrition, community and psychosocial support. Though in 2003 drug supply 
in ART-prescribing clinics was still patchy, the programme’s parallel-systems approach 
to drug ordering, distribution and monitoring, had by the end of 2004 regulated supply. 
The programme also quickly mobilised Global Fund resources that became available 
from 2003; rapidly recruited and trained staff, for instance nurses and counsellors with 
ART-specific knowledge; and continually expanded their resource drive. Again, results 
were not immediate; in 2003-4 doctors dealing with ART in then-operational clinics were 
overwhelmed with patients and staffing levels are still hard to maintain. The programme 
also quickly constructed appropriate infrastructure, including building and expanding 
clinics, starting with initiator sites  which were receiving the most referrals. Finally, to 
work well, the scaleup had rapidly to establish consensus with all ‘stakeholders’ or 
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partners: patients, local communities, community-based organisations, HIV activists, 
interested national and international NGOs, and medical professionals at every level. 
From the beginning of the scaleup, resources were devoted to managing these 
partnerships so they could have rapid outcomes (Abdullah, 2006). One cannot scale up 
quickly, alone.  
 
The detail, breadth, and speed of the scaleup’s administrative technology  constituted a 
micropolitics of the epidemic. It set up participants in the scaleup - patients and staff - as 
citizens functioning within the HIV epidemic:  as HIV citizens with specific means of 
ensuring access to and effectiveness of treatment.  However, some of this technology’s 
elements, for instance the strong collaborations which guaranteed its speed, were also 
components of other key technologies in the scaleup.  
 
Partnership technologies 
 
Technologies of partnership were central to scaleup. ‘Partnership’ is a problematic matter, 
rarely as easy to establish or as equal as it proclaims. It is often invoked in HIV and 
development discourse, where commitment to it can be a condition of receiving funding 
(Heywood, 2004), but ignored or exploited in practice. Campbell's chapter provides many 
southern African examples of partnership discourse without practice. In other South 
African provinces it has been questionably successful in supporting scaleup, particularly 
early on (Beresford, 2004) The Western Cape scaleup also generated examples of the 
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difficulties of national government, local government and civil society partnerships. 
However, it demonstrated that is possible to build associations of different and differently 
powerful ‘stakeholders’ in limited, contingent partnership working for specific goals 
around HIV treatment.  In the Western Cape, such associations were essential for 
operational reasons, to deliver the medical and ‘psychosocial’ aspects of HIV treatment 
within resource-constrained circumstances, as well as ideologically, to promote a 
"positive spiral…where all parties were working together to do their best" in a 
programme seen to be "innovative, responsive and inclusive" (Abdullah, 2004: 258). 
Such associations construct another important level of citizenship in the HIV epidemic, 
building that citizenship's relationships and identities as well as its effectiveness. 
 
The Western Cape already had high levels of HIV ‘partnership’-derived cultural and 
social ‘capital’ - HIV knowledge and social associations - that enabled ART scaleup 
partnerships.  For instance, PMTCT knowledge and practices encouraged ART literacy 
and enrolment from the start of scaleup. With only 33% of pregnant HIV positive women 
enrolled in such programmes worldwide, largely because of low antenatal clinic 
attendance (WHO, 2008), many countries cannot draw on such preexisting sociocultural 
capital. Some other South African provinces also have much lower antenatal HIV testing 
rates (Republic of South Africa, 2008). Scaleup was further enabled by province expertise 
derived from earlier ART trial and demonstration projects, and related collaborations 
between clinicians, researchers, local health officials, and international and national 
NGOs and CBOs.  Unlike programmes in many other high-prevalence epidemics, the 
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Western Cape scaleup could cite such existing effective partnerships when making 
funding applications: a considerable strength.   
 
However, scaleup could not rely on preexisting partnerships to deal with the numbers 
requiring treatment across the whole province. The Department of Health had to create a 
generalised technology of partnership across all levels and sites of medical engagement. 
The scaleup devolves ART, often considered too complex and resource-intensive for 
primary health care environments, hence viewed as draining resources from and 
devaluing them,  to precisely these environments, which are involved, too, in the 
programme's planning and monitoring.  The scaleup’s universal provision also lets 
primary-sector medical professionals address HIV much more effectively than before. 
Pre-scaleup, they were often reported as stigmatising, unhelpful and fatalistic (Squire, 
2007). These reactions might be attributable partly to lack of treatment education 
(Beresford, 2004); partly to the ‘deskilling,’ frustrating and depressing effects of being 
unable to access proven effective treatment for fatally ill patients. In 2002, a doctor was 
fired from his government job for allowing prophylactic ART prescription to raped 
women. By contrast, the medical alliances promoted by the Western Cape scaleup support 
highly motivating partnerships in cutting-edge HIV treatment and care. 
 
Partnership also extends to new professional groups. Pharmacists are specifically 
addressed as active scaleup partners (Naimak, 2006). ‘Lay’ HIV counsellors, mostly with 
no prior medical or psychological expertise, are trained to support people on ART at a 
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maximum ratio of 1: 30, either visiting patients at home, giving onsite one-to-one 
counselling, or facilitating onsite groups – much as counsellors work with support groups 
on PMTCT programmes. Treatment expansion functioned for existing lay HIV 
counsellors, as for medical professionals, as a powerful incentive, turning their previous 
role of dispensing comfort and nutritional advice into one of providing effective medical 
referrals, alongside information and socioemotional support for 'living positively'. The 
partnership between lay counselling and the scaleup, building up a new, salaried 
profession of considerable size, has involved some economically-motivated 
compromises. Status differences between lay counsellors and nurses remain controversial, 
with the former paid by private companies tendering to the province’s Department of 
Health, and therefore lacking health department benefits: holiday and sickness pay, 
unemployment insurance. This differential promotes turnover, constrained however by 
unemployment rates of over 50% in the townships, informal settlements and rural areas 
where most counsellors live. As in this case, partnerships are never relations between 
exact equals. They involve negotiation towards contingent, pragmatic consensuses, often 
hard-won, on specific issues at particular times.  
 
The scaleup encourages but does not mandate partnership between medical facilities and 
local NGOs and CBOs. It asks them to collaborate in deciding and delivering support 
mechanisms. Some sites initially even made joint clinican-NGO or CBO decisions about 
which patients to admit to the first stages of rollout. The chosen method of education – 
collective or individual – and adherence support - onsite or in the community, one-to-one 
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or in a group, counsellor-led or facilitated by family and friends  - appears not to affect 
outcomes significantly. However, collaboratively agreed-on provision seems important, 
given less favourable outcomes in other settings that provide support less systematically, 
for instance, through GP practice (Abdullah, 2004; Infectious Disease Epidemiology  
Unit/Department of Health, 2006). In addition, the province’s failure to exceed two-thirds 
provision may relate partly to NGOs’ continuing struggles to deliver the education and 
support they aim for.   
 
Involvement in scaleup gave NGOs and CBOs, too, new impetus. For example, some 
CBOs providing homecare were able to go beyond palliative care for the first time. In this 
high-prevalence epidemic, almost all CBOs’ and NGOs’ remit now includes HIV, 
precipitating multiple partnership possibilities. However, non-HIV-related NGOs and 
CBOs may be excluded from the new resources that scaleup brings, and external funders’ 
requirement that applicants prioritise HIV can skew their work. For instance, Western 
funders frequently ask proposals on child poverty and abuse, and gender-based violence, 
to foreground HIV. The Western Cape provincial government has addressed this issue by 
expanding work in these areas in addition to its HIV programmes.  
 
The scaleup’s commitment to partnership also means that the programme aims to build 
the provincial health system generally, alongside HIV care. Many health professionals are 
themselves HIV positive, so health services gain directly from HIV treatment.  More 
generally, full scaleup is impossible in poorly-ser
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level, without wholesale health system improvements. HIV’s high demands on health 
services throughout subsaharan Africa have led to the mainstreaming of this double-track 
approach.  Its implementation is not entirely successful. The Western Cape’s failure to 
exceed two-thirds ART provision seems partly determined by continuing local health 
system deficits. Recent increases in patients lost to followup (Boulle et al., 2008) may 
indicate a system reaching capacity. 
 
Partnership technologies can also offer an important alternative to the dichotomisation of 
HIV treatment and prevention. Treatment is often criticised as a diversion from 
prevention, supplanting it in policy, obviating considerations of prevention in HIV 
activism and in people's everyday lives (Davis, Mykhalovskiy, this volume), and 
abrogating scarce resources in the developing world. Though UNAIDS emphasises the 
necessary synergy of the two, HIV treatment is still often seen as creating divisions within 
health systems and stripping resources from prevention, which is associated less with 
scientifically-validated, prestigious, drug-driven and resource-intensive technologies, and 
more with behavioural technologies. The Western Cape’s ‘partnership’ technology 
however means that scaleup is delivered alongside treatment literacy, prevention 
resources such as condoms, support for safe sex negotiation particularly for women, and 
general HIV education. This partnership is seeded by the educative effects of PMTCT 
programmes, particularly since these programmes reach almost all reproductive-age 
clinic-attending women. A related partnership, between scaleup and testing, has both 
prevention and treatment implications. As in other epidemics, testing became justifiable 
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once treatment was available.  On the back of universal PMTCT and the ART rollout, 
antenatal testing rates have risen to 94.8% (Draper et al., 2007).(I still need general adult 
testing rate) 
 
 Declining HIV incidence and rising HIV awareness among younger people; and rising 
age of sexual debut especially among young women (Flisher et al., 2006) - with figures 
better than in other South African provinces - suggest the effectiveness of the Western 
Cape scaleup’s technology of treatment and prevention 'partnership'. While the province’s 
early comprehensive treatment programme marks it out, that programme seems to work 
alongside its integrated address to prevention, to constitute an important, social level of 
active HIV citizenship in people’s sexual talk and actions. 
 
Campbell vividly describes the difficulties of building partnerships, even within well-
resourced and committed HIV prevention and education programme. Often, ‘partnership’ 
operates largely at the level of discourse.  The Western Cape programme does not 
however rely on discourse or voluntaristic practice, but devotes considerable resources to 
fostering and managing partnerships at every level. In some situations, Campbell 
describes how HIV is not a personal priority ‘owned’ by all stakeholders, and how 
partners are separated by prohibitive geographical and social distances. In the Western 
Cape scaleup, the recognition of strong common interests between partners was promoted 
from the start through a concurrent public education programme, and peer education in 
schools, constructing the province’s high levels of HIV cultural capital. Partnership is 
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also fostered by the programme’s decentred processes, carried out by primary healthcare 
facilities, nurses, counsellors and NGOs clustered together within highly-affected 
neighbourhoods: everyone is close to the programme.  Finally, perhaps most importantly, 
the promotion of treatment with education and prevention by the provincial health 
department, radically encourages partnership. HIV technologies that do not or cannot 
address the condition first as one that needs medical treatment, undermine their rationale 
by ignoring their own medical definition of their object, however much they are able to 
address other aspects of the condition.  
 
The partnership-dependent delivery of ART, related prevention resources, and education 
for both treatment and prevention works horizontally and vertically, to develop social and 
cultural 'capital' (Campbell, 2003) within and across differently powerful groups: medical 
professionals; local politicians and officials; NGOs; CBOs; and community members 
who are patients, clients, service users and activists.  These partnership-derived 
biosocialities of the epidemic are also part of a more broadly and actively articulated HIV 
citizenship, operating within and between these groups. For instance, drawing on ART 
programme partnerships, the Western Cape has supported campaigns against gender-
based violence, a phenomenon linked to the epidemic in many ways (Jewkes, 2009). In 
these campaigns, HIV citizenship works both vertically, in partnerships between HIV-
related CBOs, the health department, and international donors; and horizontally, in 
partnerships between HIV positive women and men, and between people of different HIV 
statuses with common concerns about gendered violence and abuse.   
84 
 
 
 
 
 
Partnership technologies can only go so far. HIV programme ownership is not, as 
Campbell  notes, spontaneously shared; there is always a struggle. Building bridging 
social capital between individuals and organisations with differential access to resources, 
depends on addressing this discrepancy. The Western Cape scaleup has achieved an 
effective partnership technology that built HIV citizenship, not just through the 
partnership technology itself, but also through its commitment to a specific technology of 
HIV treatment citizenship, that addressed power relations directly. Treatment citizenship 
is a constitutive element of all HIV citizenship in the era of treatment possibility. In the 
Western Cape scaleup, however, the formations of representation and action that make up 
HIV treatment citizenship have a particular role. 
 
HIV treatment citizenship 
The Western Cape scaleup  deploys a technology of HIV treatment citizenship that is less 
explicitly planned than the other technologies and harder to measure or record, but that is 
frequently remarked on in commentaries on the programme (Robins, 2008) This 
treatment citizenship technology is characterised by people's self-representation and 
action as members of HIV collectivities. The collectivities present as political, in the 
sense that they contest the power relations of HIV treatment, through education, social 
dialogue, and activism. 
 
Some treatment citizenship technology is easily apparent as such.  For instance, the 
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Khayelitsha ART demonstration project assessed applicants partly on the basis of their 
involvement with local HIV CBOs, at this point largely oriented towards treatment 
activism. Active treatment citizenship was thus a treatment criterion. The scaleup's 
implementation partnerships with NGOs and CBOs quickly also became partnerships 
with campaigners and activists. More generally, some patients, relatives and friends 
engaged strongly with medical and political institutions from the start, as in other 
epidemics (Epstein, 1996), demanding first treatment for opportunistic infections, then 
PTMCT, then ART, then specific medications not available within local or national 
protocols or supply chains. Many such campaigns appeared most strongly and first in this 
province, though the treatment-activist engagement of people throughout South Africa, 
especially via TAC, has been strong (Naimak, 2006). Robins (2008) describes this 
activism as a form of health citizenship, pursuing the rights guaranteed within the 
famously progressive South African constitution, which upholds the principles of Batho 
Pele – People First - and a ‘better life for all.’ He points to the strategic use of rights 
discourse within TAC which managed to articulate demands for ART in a national 
context of  'AIDS denialism', and in a language shared with the international governance 
discourse of the WHO and UN (see also Mbali, 2005). 
 
However, across the Western Cape scaleup only some patients and fewer doctors 
participated in campaigning assertions of treatment citizenship. Activism is just the most 
visible face of treatment citizenship technology; the specificities of the condition 
necessitate other forms as well. HIV's stigmatisation and perceived transgressiveness 
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consistently constrain activism. HIV’s treatment normalisation may also divert activism, 
as in developed-world countries (Davis, Flowers, Mykolovskiy, this volume). However, 
the difficulties of living with high-prevalence HIV, low-resources and  variable ART 
access, as in South Africa, differently limit activist commitment. The other kinds of 
treatment citizenship technology that play a part in the Western Cape’s scaleup, are HIV 
education, and HIV sociality. 
 
Treatment education, driven by the possibility of treatment even before treatment was 
available, has been integral to the scaleup’s treatment citizenship technology. The 
province expanded ART education in parallel with scaleup, and some treatment literacy is 
required of all patients starting ART. Even in 2001, well before national education 
programmes on the issue, let alone ART or indeed other treatment availability, there was 
some province-wide education on treatment, as well as testing, healthy living, and 
prevention - by NGOs, CBOs, popular media, and the province itself.  The province's 
rollout of PMTCT programmes also educated people who, seeing the healthy babies of 
HIV positive women, started to demand the drugs for themselves. ART literacy in the 
Western Cape at the beginning of scaleup seemed relatively high. Even in 2001, HIV-
infected people in the main periurban area had relatively good levels of knowledge of 
ART and other drugs (Squire, 2007).  
 
Much treatment education was informally  pursued, not formally delivered. Given 
government criticism of ART as exploitative and toxic, knowledge of it had to be wrested 
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from competing sources of information. Patients' unexpectedly high levels of adherence 
often seems related to this self-educated engagement. Anecdotally, many clinicians report 
that people taking ART know the names of their drugs, alternatives available, and 
possible sideeffects, to a much greater extent than patients living with other chronic 
conditions                                                                                                                                                              
such as diabetes and heart disease. Actively pursed, contested education thus seems a 
powerful aspect of the Western Cape’s treatment citizenship, as it has been in elsewhere. 
As is sometimes argued of Uganda (Epstein, 2006), HIV began stabilising  when many 
within the epidemic became active, educated ‘HIV citizens.’ In the Western Cape, this 
happened first in the treatment, rather than prevention, arena.  
 
Educated treatment engagement has spread outward from the Western Cape, particularly 
to family members living elsewhere. For instance, in the group of those ‘lost to 
(treatment)  followup’ in the scaleup, a term which might suggest uncommitted or 
disorganised patients, many show high treatment commitment, and treatment planning. 
Some pregnant HIV positive women, for example, made their way to the Western Cape 
from other provinces with great difficulty, since they had no cash income for transport, to 
access its PMTCT programme, Other women and men, similarly cash-poor, came to the 
province to stay with family members and pursue their own treatment. Later, as treatment 
expanded for instance in the Eastern Cape, and as PMTCT babies were doing well, some 
patients returned home and thus were 'lost.'  Currently, the scaleup’s success means many 
patients feel free to move between medical facilities – moves which make care retention 
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statistics in a paper-based system, difficult to keep. 
 
If treatment education was informal and contested, how did it work so well? The key 
route reported by Squire’s (2007) informants, suggested by Campbell and colleagues 
(2007) in their accounts of developing 'HIV competence' in South African rural settings, 
and also indicated by accounts of the effectiveness of support and counselling groups 
(Hutchinson and Mahlalela, 2006; Flowers et al., 2006) involves not just obtaining 
knowledge, but also safe and open HIV sociality. This route recalls Rabinow's (1996) 
formulation of 'biosocial' collectivities organised around contested biological 
subjectivities.  There is a possible, though not inevitable, association between such 
sociality - which also helps constitute, for instance, the 'partnership' technology, described 
above - and the broader identifications and actions of treatment citizenship. Campbell and 
colleagues (2007) also specify that HIV competence involves owning the virus socially as 
'our problem,' through the horizontal social-capital linkages described earlier as part of 
politicised partnership; and social effectivity.  This account comes close to a Freirian 
programme for generating social change through collective critical dialogue (Freire, 
1973).  Western Cape treatment protocols, from the demonstration projects on to the 
scaleup, clearly embedded citizenly ART understanding and effectivity within sociality. 
They asked for NGOs, CBOs, and family and friends' involvement. Many required the 
participation of a familial or friend 'treatment assistant'. Building on the Western Cape 
demonstration projects, WHO ART scaleup guidelines also emphasise community and 
family support.   
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In ART scaleup discourse, therefore, people taking treatment, and their treatment 
assistants, are positioned as effective treatment citizens alongside medical professionals, 
forming contingent alliances with medical discourse, negotiating with it, disseminating 
this negotiated treatment knowledge socially, and negotiating with it further in the 
process (Robins, 2008). This engagement is borrowed for public discourse, as it was in 
developing-world epidemics, from its earlier activist and community incarnations (Davis 
et al., 2006; Epstein, 1996). In the Western Cape, this discourse was at least partly 
effective in practice. The drive towards treatment literacy in advance of scaleup set up an 
important HIV sociality of people throughout the province, discussing ART in families 
and friendship networks as well as CBOs and NGOs. This sociality appeared in the early-
2000s concern of many people living around the demonstration and initial scaleup sites to 
'speak out' about their status, and how one can live with and be treated for HIV as an 
illness, not as a sign of social or spiritual transgression (Squire, 2007). The sociality of 
scaleup itself, institutionalised in decentred structure of local clinics' implemention 
strategies, allowed patients' groups and CBOs input into guidelines for starting and 
supporting treatment. These discussions migrated outward into broader family, friendship 
and community socialities. Such a socialised treatment citizenship technology seems now 
to extend across the province, and may be another factor contributing to the Western 
Cape's high HIV test rates, and the rise in sexual debut age in the province (Flisher et al., 
2006) – something often said to be associated with the plateauing of other high-
prevalence epidemics (Epstein, 2006).   
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Treatment citizenship could be seen as a kind of ‘capacity building.’ Campbell is rightly 
sceptical about this process, describing it as fatally self-undermining.  Generally, efforts 
at building treatment citizenship technologies, or Campbell's broader category of HIV 
competence, try to correct resource inequities by transferring resources defined by those 
that have them, who also decide how they shall be transferred and when they have been 
successfully moved over.  Such programmes' understanding of power differences is 
undercut by their re-performance of these differences precisely while combatting them. 
The contested nature of politics (Mouffe, 2005) is acknowledged in analysis, erased in 
implementation. In the case of the Western Cape scaleup however, the technology of 
treatment citizenship was to a large extent defined, appropriated and developed by the 
people requiring it.   
 
Treatment citizenship is not equivalent to HIV citizenship in general, but its technology 
may build that broader formation. We have seen how the province's prevalent forms of 
treatment citizenship seem associated with high levels of HIV testing, and changes in 
sexual relationship patterns. In addition, Western Cape treatment citizenship generated, 
and continues to support, jointly-developed campaigns by medical professionals, NGOs 
and CBOs, for cheap access to key license-protected drugs; but also NGOs' and CBOs' 
development of support services, for instance around gender violence. CBOs' 
involvement in treatment education has led to stronger prevention and education 
programmes, an integration of great concern to people of all statuses in South Africa. 
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With the help of a supportive doctor, Western Cape women enrolled in PMTCT 
programmes began educating other pregnant positive women, a commitment now 
formalised in 'Mothers2mothers2B’ groups which have spread across South Africa and 
other southern African countries (http://www.m2m.org/). ART support groups, 
concentrated at the beginning of treatment, have spun off income generation projects. 
People 'speaking out' about HIV as a treatable, liveable-with illness, promote dialogue not 
just about HIV status and treatment, but also about HIV's nature, prevention, and 
implications for the nation and the future (Daniel and Squire, 2009). 
 
Even in talking of their treatment ‘rights’ as citizens, people living with HIV in the 
Western Cape assert ‘rights’ in ways that are not restricted to treatment or health 
citizenship exclusively, but that do not either become generalised assertions of ‘human’ 
rights (Robins, 2008). Between 2001 and 2004, for example, Squire's interviewees 
articulated 'rights' particularly and transitively in relation to HIV's impact in different 
fields, specifying entitlements to goods in health, social, employment and education 
fields. HIV positive people demanded treatment, but also food for their children once 
PTMCT programmes - which provide infant formula - had been completed, and food for 
themselves to promote the success of ART (an issue of which scaleup programme 
directors were well aware –see Abdullah, 2004). They asked for funeral grants for family 
members who died of HIV, and for flexible disability grants, since even with ART, 
continuous paid work can be problematic for HIV positive people, assuming they can get 
such work. They wanted training that would enable them to work in areas suitable for 
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chronically ill people.  This specificity about who has rights, and to what, clarifies 
convergences and distinctions between HIV positive and other citizens, that is, their 
equivalent identities (Mouffe, 2005), while also defining contemporary HIV citizenship 
in ways that go beyond treatment citizenship. The technology of HIV citizenship built up 
through the rollout can then be summarised as a pragmatic citizenship, equivalent with 
but not identical to the citizenship of the non-HIV affected, that lays out commonalities 
with other citizens, while still marking the important particularities of the condition.  
 
In addition, people living with or alongside the demonstration projects and scaleup have 
developed HIV citizenship as a moral formation. They describe  how to live well as HIV-
positive citizens in ways that speak back to HIV's social and religious pathologisation, 
and that closely match broader South African understandings of good conduct and 
appropriate ways of living. They adumbrate a pragmatic ‘somatic ethics’ (Rose, 2007: 
252) involving care of the self through cleanliness, diet and exercise; care of others – 
children, partners and neighbours; cooking and cleaning; paid work when possible; and a 
social commitment to speaking and acting truthfully and ethically  - in this case, about 
HIV. These formulations of care of self and others within HIV citizenship technology 
relate to the principle of ubuntu, the humanity inherent in living through and for others, 
mentioned by some of Squire's (2007) interviewees and a frequent point of cultural and 
political reference in South Africa. Interviewees emphasised that a person living with 
HIV was ‘still’ a person and not an animal, and must be socially recognised as such, 
despite their specific characteristics and requirements.  Such formulations embed 
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politically equivalent HIV citizenship in ethical but still pragmatic considerations about 
how to live well in specific contexts, including that of HIV. 
 
We have suggested that the Western Cape ART scaleup can be analysed as working 
through a triad of administrative, partnership and citizenship technologies, built up from 
near-zero in some places and cases, to high and largely self-sustaining levels. The scaleup 
technologies  were not necessarily or exactly connected with people’s development of a 
wider HIV citizenship; they had some independent fields of action. However, it is clear 
that they contributed to the constitution of this broader HIV citizenship within the 
province. These technologies can be worked with in other contexts, but crucial to  their 
effectiveness has been their recognition of factors that must be addressed locally. Such 
particularity, instantiated in the scale-up's commitment to neighbourhood-developed 
strategies, renders the technologies resistant to exact translation.  
 
The technologies also present substantial problems of contemporary and future 
implementation, derived from their own heterogeneities and contradictions, as well as 
from those that appear in their relation with other, medical social and political 
technologies. 
 
The limits of scaleup technologies 
Throughout the scaleup, its technologies have encountered a number of resistances, some 
of which are likely to persist and strengthen. The scaleup has not made HIV citizens of 
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the 20 000 people estimated to be HIV positive and to need treatment, who are not 
accessing it. Partial explanations for this may lie, as mentioned earlier, in the limitations 
of the programme's administrative technology, particularly in health service resources 
reaching their limits.  In addition to the general programme, the health department is now 
targeting the specific local problematics of HIV in relation to older men, schoolchildren, 
sex workers and truck drivers. The scaleup may also have encountered a geographic limit 
in reaching people who can access clinics by walking or by car; many rural settlements 
are not served by roads. As people live longer, the complications of longterm ART use 
become more common, more people progress to ART, increasing numbers move onto 
expensive second- and third-line drug regimes, and incidence remains high, problems will 
multiply. Men, who have little contact with South African health services, are 
consistently underrepresented in treatment at 30% of the total - though more women are 
HIV positive (Boulle et al., 2008). Women continue to face gendered stigmatisation and 
disclosure difficulties (Ratele and Shefer, 2002; Rohleder and Gibson, 2006). HIV's 
dramatic impact at diagnosis and its stigmatisation persists, in South Africa and globally 
(Flowers, this volume; Stevens and Hildebrandt, 2006). Acknowledging the condition, 
disclosing (Flowers, this volume) embarking on lifelong medication, and dealing with 
sideeffects and HIV's ongoing medical uncertainties (Davis, this volume; Olley et al., 
2005) continue to be difficult. New prevention issues arise for those taking ARTs or 
simply having sex in the ART era, particularly for women who are now formulating their 
AIDS-era sexualities in new ways. Younger people particularly are becoming accustomed 
to, even bored with HIV, as this high-prevalence epidemic moves into a second decade of 
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public awareness and action.  
 
All these characteristics suggest the importance of 'psychosocial' factors to which, as 
mentioned earlier, medical, NGO and CBO partnership technology in the scaleup have 
not yet made full responses. Given the newness, high prevalence, particularity and fluidity 
of this epidemic, an expectation that neighbourhoods and communities could develop 
their own fully adequate and sustainable support mechanisms to cover all of these areas 
of the 'psychosocial' out of ART partnership technologies, would be overoptimistic. The 
'psychosocial' itself may need redefinition within ART technologies (Wilbraham, this 
volume). Moreover, while the scaleup programme certainly acknowledges the multiple 
dimensions of what we have called 'treatment citizenship,' that citizenship's overtly 
political and educative elements have been privileged. Its more diffuse sociality is harder 
to describe, let alone encourage; and it is always under challenge.  For though everyone in 
South Africa is in some way 'living with' HIV, the 'equivalence' between different citizens 
- between HIV positive women and men, the positive well and the symptomatic, the 
infected and the affected, parents and their children - is approximate, changing, and 
contested.  
 
A further criticism addresses the scaleup's medical focus. Does this focus inevitably 
'medicalise' HIV citizenship?  Treatment-oriented responses to the pandemic are 
frequently accused of reducing people's relations with HIV to that of patients and research 
subjects'relations to disease and virus. This accusation also applies to recent treatment-
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oriented prevention discourse that, instead of focusing on personal and social action, 
promotes early (Granich et al., 2009) or prophylactic (Rosengarten, this volume) ART. 
Microbicides and circumcision, ART post-sexual assault, even condoms and clean 
needles, can also be conceptualised as medicalisations of prevention.  Such criticisms 
often link to broader condemnations of subjects' and whole economies' cooption by 
pharma-capital, and of developing countries' surveillance by international NGOs such as 
the WHO. However, to equate treatment activism, at for instance the Western Cape 
neighbourhood  or local government level, with international treatment capitalism and 
postcolonial regulation, seems patronisingly over-simplifying.  There is, too, considerable 
heterogeneity within the biopolitics of both international NGOs and pharmacological 
companies, which are also not the least socially responsible or responsive corporate 
sector. South Africa is in addition, like many other subsaharan African countries, trying to 
expand its own 'small pharma' production of ART drugs, a development that, like 
developing countries’ production of generics, complicates biocapital analysis.  
 
The 'medicalisation' critique of treatment scaleup is most aptly countered in the Western 
Cape case by the programme’s actualities. Even when the scaleup’s non-medical partners 
developed medical expertise, they did not become medicalised citizens wholly coopted by 
western medical discourse and practice. Most people taking ART for instance also use 
traditional and complementary approaches they think appropriate, often in consultation 
with their doctors, as indeed happens across developing and developed-world HIV 
epidemics and in developing-world health care in general. While patients have high 
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treatment literacy and commitment, they are not generally strongly identified with 
medical expertise. Their relations with their doctors tend to be relatively conventional 
partnerships, with patient and practitioner roles clearly separated.  More importantly, the 
non-medical technologies that we have described were key to scaleup’s successs. 
Administrative and partnership technologies were formulated and implemented with 
relative autonomy from the medical technologies of ART. Even treatment citizenship, the 
technology most focussed on medicine, configured health information in terms of 
activism and social dialogue, and had important associations with broader forms of HIV 
citizenship.  
 
Conclusion  
How will the Western Cape programme’s scaleup technologies fare in future? The plan is 
to double enrolment yearly for the next five years, particularly focusing on 
underrepresented men. As more patients stay on therapy, more will move to expensive 
second-line drugs. Numbers of people requiring treatment will continue to rise well into 
the next decade and beyond, if numbers of new cases do not fall (Western Cape, 2006). 
The resourcing of such extensive treatment, even given generic provision and domestic 
manufacture, will be a growing concern. The psychological, social and political 
consequences for large fractions of the population living long-term with difficult medical 
treatment are hard to predict. Achmat and Simcock (2007) are optimistic about the 
ameliorative effects of longterm treatment combined with prevention, education and 
community mobilization – the wider HIV citizenship technologies discussed above. 
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Draper and cowriters (2007) call for largescale and thoroughgoing initiatives that do not 
look qualitatively different from those currently operating. The citizenship, administrative 
and partnership strategies discussed here, may, despite their limitations, be able to address 
at least some of the future conditions of this epidemic, and perhaps of others. 
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